BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16259644)

  • 1. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
    Li Z; Clarke MP; Barker MD; McKie N
    Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
    Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
    Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter.
    Weber BH; Vogt G; Wolz W; Ives EJ; Ewing CC
    Nat Genet; 1994 Jun; 7(2):158-61. PubMed ID: 7920634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
    Soboleva G; Geis B; Schrewe H; Weber BH
    J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.
    Felbor U; Doepner D; Schneider U; Zrenner E; Weber BH
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1054-9. PubMed ID: 9152224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration.
    De La Paz MA; Pericak-Vance MA; Lennon F; Haines JL; Seddon JM
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1060-5. PubMed ID: 9152225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
    Lin RJ; Blumenkranz MS; Binkley J; Wu K; Vollrath D
    Am J Ophthalmol; 2006 Nov; 142(5):839-48. PubMed ID: 16989765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model for Sorsby fundus dystrophy.
    Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
    Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features.
    Tabata Y; Isashiki Y; Kamimura K; Nakao K; Ohba N
    Hum Genet; 1998 Aug; 103(2):179-82. PubMed ID: 9760202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorsby's fundus dystrophy. A South African family with a point mutation on the tissue inhibitor of metalloproteinases-3 gene on chromosome 22.
    Peters AL; Greenberg J
    Retina; 1995; 15(6):480-5. PubMed ID: 8747441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
    Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
    Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
    Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorsby fundus dystrophy: Insights from the past and looking to the future.
    Anand-Apte B; Chao JR; Singh R; Stöhr H
    J Neurosci Res; 2019 Jan; 97(1):88-97. PubMed ID: 30129971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
    Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
    J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.
    Majid MA; Smith VA; Newby AC; Dick AD
    Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sorsby's fundus dystrophy. A genetically homogeneous disease].
    Felbor U; Weber BH
    Ophthalmologe; 1998 May; 95(5):287-90. PubMed ID: 9643018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
    Fogarasi M; Janssen A; Weber BH; Stöhr H
    Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
    Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
    Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.
    Langton KP; McKie N; Curtis A; Goodship JA; Bond PM; Barker MD; Clarke M
    J Biol Chem; 2000 Sep; 275(35):27027-31. PubMed ID: 10854443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.